Data demonstrated multiple clinical benefits beyond linear growth— NDA supported by data from three randomized, double-blind, ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

B-type natriuretic peptide is released by cardiac myocytes in response to wall stretch. There are many hemodynamic effects of BNP which are beneficial in the setting of decompensated congestive ...

The chambers release peptide hormones, including ‘atrial natriuretic peptide’ and ‘brain natriuretic peptide’, which help regulate the balance of fluid in the body by affecting the kidneys.

Atrial natriuretic peptide (ANP) is similar to b-type natriuretic peptide (BNP) in the hemodynamic effects. ANP is not measured clinically unlike BNP. It is released in response to myocyte stretch ...

N-terminal probrain natriuretic peptide and troponin for assessing ... and renal insufficiency by lenalidomide. - Place of induction therapy before high-dose/intermediate-dose melphalan and ...

Brain natriuretic peptide (BNP), first discovered in porcine brain, is principally produced by the heart. Unlike atrial natriuretic peptide (ANP), BNP is largely derived from the ventricles.